Cargando…

Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India

BACKGROUND & OBJECTIVES: The increasing prevalence of extended-spectrum β-lactamases (ESBLs) has abated therapeutic options worldwide. This study was undertaken to investigate the molecular profile and resistance patterns of ESBLs among clinical isolates of Escherichia coli and Klebsiella pneumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gautam, Vikas, Thakur, Anjana, Sharma, Megha, Singh, Avinash, Bansal, Shruti, Sharma, Aditi, Kapil, Arti, Das, Bimal Kumar, Sistla, Sujatha, Parija, Subhash Chandra, Veeraraghavan, Balaji, Prakash, John Antony Jude, Walia, Kamini, Ohri, V.C., Ray, Pallab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563744/
https://www.ncbi.nlm.nih.gov/pubmed/31219085
http://dx.doi.org/10.4103/ijmr.IJMR_172_18
_version_ 1783426601984196608
author Gautam, Vikas
Thakur, Anjana
Sharma, Megha
Singh, Avinash
Bansal, Shruti
Sharma, Aditi
Kapil, Arti
Das, Bimal Kumar
Sistla, Sujatha
Parija, Subhash Chandra
Veeraraghavan, Balaji
Prakash, John Antony Jude
Walia, Kamini
Ohri, V.C.
Ray, Pallab
author_facet Gautam, Vikas
Thakur, Anjana
Sharma, Megha
Singh, Avinash
Bansal, Shruti
Sharma, Aditi
Kapil, Arti
Das, Bimal Kumar
Sistla, Sujatha
Parija, Subhash Chandra
Veeraraghavan, Balaji
Prakash, John Antony Jude
Walia, Kamini
Ohri, V.C.
Ray, Pallab
author_sort Gautam, Vikas
collection PubMed
description BACKGROUND & OBJECTIVES: The increasing prevalence of extended-spectrum β-lactamases (ESBLs) has abated therapeutic options worldwide. This study was undertaken to investigate the molecular profile and resistance patterns of ESBLs among clinical isolates of Escherichia coli and Klebsiella pneumoniae at four tertiary care centres in India. METHODS: Clinical isolates of E. coli and K. pneumoniae were collected from the All India Institute of Medical Sciences (AIIMS), New Delhi; the Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry; Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh and Christian Medical College (CMC), Vellore, over one and a half year period. Antimicrobial susceptibility was determined by Kirby-Bauer disc diffusion method. ESBLs were confirmed phenotypically, and multiplex PCR was performed to identify genes for β-lactamases (bla(TEM), bla(SHV), bla(OXA-1), bla(CTXM-1), bla(CTXM-2), bla(CTXM-9) and bla(CTXM-15)). RESULTS: Among 341 E. coli isolates collected during the study period, 171 (50%) harboured bla(TEM), 145 (43%) bla(OXA-1), 70 (21%) bla(CTXM-1), 19 (6%) bla(SHV) and four (1%) harboured bla(CTXM-2). Phenotypically, combined disc test detected ESBL production in 98/298 (33%) E. coli. Among 304 K. pneumoniae isolates, 115 (38%), 89 (29%), 83 (27%), 64 (21%) and two (0.6%) harboured bla(TEM), bla(OXA-1), bla(CTXM-1), bla(SHV) and bla(CTXM-2), respectively. Combined disc test (CDT) detected ESBL production in 42 per cent K. pneumoniae. Most of the bla(CTXM-1) positive isolates were also bla(CTXM-15) positive. The carbapenem susceptibility ranged from 56 to 88 per cent for E. coli and from 20 to 61 per cent for K. pneumoniae. Antibiotic sensitivity patterns showed that colistin (CST) was the most sensitive drug for both E. coli (271/274, 99%) and K. pneumoniae (229/234, 98%). INTERPRETATION & CONCLUSIONS: The prevalence of ESBL among four study centres varied, and bla(TEM,) bla(OXA-1) and bla(CTXM-15) were the most common genotypes in E. coli and K. pneumoniae isolates in India. The growing carbapenem resistance and emerging colistin resistance warrant the judicious use of these antimicrobials.
format Online
Article
Text
id pubmed-6563744
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-65637442019-06-14 Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India Gautam, Vikas Thakur, Anjana Sharma, Megha Singh, Avinash Bansal, Shruti Sharma, Aditi Kapil, Arti Das, Bimal Kumar Sistla, Sujatha Parija, Subhash Chandra Veeraraghavan, Balaji Prakash, John Antony Jude Walia, Kamini Ohri, V.C. Ray, Pallab Indian J Med Res Original Article BACKGROUND & OBJECTIVES: The increasing prevalence of extended-spectrum β-lactamases (ESBLs) has abated therapeutic options worldwide. This study was undertaken to investigate the molecular profile and resistance patterns of ESBLs among clinical isolates of Escherichia coli and Klebsiella pneumoniae at four tertiary care centres in India. METHODS: Clinical isolates of E. coli and K. pneumoniae were collected from the All India Institute of Medical Sciences (AIIMS), New Delhi; the Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry; Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh and Christian Medical College (CMC), Vellore, over one and a half year period. Antimicrobial susceptibility was determined by Kirby-Bauer disc diffusion method. ESBLs were confirmed phenotypically, and multiplex PCR was performed to identify genes for β-lactamases (bla(TEM), bla(SHV), bla(OXA-1), bla(CTXM-1), bla(CTXM-2), bla(CTXM-9) and bla(CTXM-15)). RESULTS: Among 341 E. coli isolates collected during the study period, 171 (50%) harboured bla(TEM), 145 (43%) bla(OXA-1), 70 (21%) bla(CTXM-1), 19 (6%) bla(SHV) and four (1%) harboured bla(CTXM-2). Phenotypically, combined disc test detected ESBL production in 98/298 (33%) E. coli. Among 304 K. pneumoniae isolates, 115 (38%), 89 (29%), 83 (27%), 64 (21%) and two (0.6%) harboured bla(TEM), bla(OXA-1), bla(CTXM-1), bla(SHV) and bla(CTXM-2), respectively. Combined disc test (CDT) detected ESBL production in 42 per cent K. pneumoniae. Most of the bla(CTXM-1) positive isolates were also bla(CTXM-15) positive. The carbapenem susceptibility ranged from 56 to 88 per cent for E. coli and from 20 to 61 per cent for K. pneumoniae. Antibiotic sensitivity patterns showed that colistin (CST) was the most sensitive drug for both E. coli (271/274, 99%) and K. pneumoniae (229/234, 98%). INTERPRETATION & CONCLUSIONS: The prevalence of ESBL among four study centres varied, and bla(TEM,) bla(OXA-1) and bla(CTXM-15) were the most common genotypes in E. coli and K. pneumoniae isolates in India. The growing carbapenem resistance and emerging colistin resistance warrant the judicious use of these antimicrobials. Wolters Kluwer - Medknow 2019-02 /pmc/articles/PMC6563744/ /pubmed/31219085 http://dx.doi.org/10.4103/ijmr.IJMR_172_18 Text en Copyright: © 2019 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Gautam, Vikas
Thakur, Anjana
Sharma, Megha
Singh, Avinash
Bansal, Shruti
Sharma, Aditi
Kapil, Arti
Das, Bimal Kumar
Sistla, Sujatha
Parija, Subhash Chandra
Veeraraghavan, Balaji
Prakash, John Antony Jude
Walia, Kamini
Ohri, V.C.
Ray, Pallab
Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India
title Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India
title_full Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India
title_fullStr Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India
title_full_unstemmed Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India
title_short Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India
title_sort molecular characterization of extended-spectrum β-lactamases among clinical isolates of escherichia coli & klebsiella pneumoniae: a multi-centric study from tertiary care hospitals in india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563744/
https://www.ncbi.nlm.nih.gov/pubmed/31219085
http://dx.doi.org/10.4103/ijmr.IJMR_172_18
work_keys_str_mv AT gautamvikas molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT thakuranjana molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT sharmamegha molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT singhavinash molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT bansalshruti molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT sharmaaditi molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT kapilarti molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT dasbimalkumar molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT sistlasujatha molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT parijasubhashchandra molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT veeraraghavanbalaji molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT prakashjohnantonyjude molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT waliakamini molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT ohrivc molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia
AT raypallab molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia